Bone Biologics (BBLG) Accounts Payables (2016 - 2017)

Historic Accounts Payables for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to $740064.0.

  • Bone Biologics' Accounts Payables rose 12050.52% to $740064.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $740064.0, marking a year-over-year increase of 12050.52%. This contributed to the annual value of $260149.0 for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Bone Biologics' Accounts Payables stood at $740064.0, which was up 12050.52% from $432330.0 recorded in Q2 2017.
  • In the past 5 years, Bone Biologics' Accounts Payables registered a high of $740064.0 during Q3 2017, and its lowest value of $159096.0 during Q1 2017.